Abstract Background and Aim: Coronary artery disease (CAD) is one of the leading causes
of death and disability around the world. Interaction between genetic and environmental …

Coronary heart disease (CHD) is a major health problem and a major cause of death in most
countries. Evidence has been presented that gene polymorphisms (Hin dIII, Pvu II and …

Lipoprotein lipase (LPL) plays a central role in lipoprotein metabolism by hydrolyzing the
core triglycerides (TGs) of circulating chylomicrons and very-low-density lipoprotein (VLDL) …

Modifications in lipoprotein lipase levels lead to elevated triglycerides and reduced high
density lipoprotein (HDL), both of which are risk factors for coronary artery disease (CAD) …

Introduction: Several polymorphisms at the lipoprotein lipase (LPL) locus are associated
with variations in LPL activity serum lipid concentrations and the risk of coronary artery …

Hyperlipidemia is a major risk factor for coronary artery disease (CAD). Lipoprotein lipase
(LPL) is an important enzyme in lipoprotein metabolism. S447X polymorphism of the LPL …

Studies have shown association of lipoprotein lipase (LPL) polymorphisms with coronary
artery disease (CAD); however, limited studies on the genetics of CAD have been done in …

Background: Lipoprotein lipase has an important role in lipid metabolism. Elevated levels of
very-low-density lipoprotein (VLDL) and low-density lipoprotein (LDL) are associated with …

Context.—Previous studies reported an association of certain polymorphisms in the
lipoprotein lipase (LPL) gene with the risk of coronary artery disease (CAD); however, these …

Lipoprotein lipase (LPL) is the rate-limiting enzyme in the hydrolysis of triglyceride-rich
lipoprotein particles (Chylomicrons and very-low-density lipoprotein). LPL polymorphisms' …